Loading stock data...

MedPlus Health Services Limited

NSE: MEDPLUS BSE: MEDPLUS

NSE
934.45 23.35 (2.56%)

Prev Close

911.1

Open Price

915.65

Volume

171,045

Today Low / High

909.75 / 937.6

52 WK Low / High

616 / 1045.3

Range

888 - 981

BSE
935.65 24.70 (2.71%)

Prev Close

910.95

Open Price

927.95

Volume

11,133

Today Low / High

912.75 / 937.2

52 WK Low / High

603 / 1052.05

Range

889 - 982

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 934.45 (target range: 888 - 981), reflecting a change of 23.35 (2.56284%). On the BSE, it is listed at 935.65 (target range: 889 - 982), showing a change of 24.7 (2.71146%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

30 Jul 915.65 2.05%
29 Jul 903.30 0.86%
28 Jul 897.75 0.09%
25 Jul 880.00 1.85%
24 Jul 889.10 -0.21%
23 Jul 902.80 -2.04%
22 Jul 911.30 -0.95%
21 Jul 895.80 1.20%
18 Jul 917.15 -1.83%
17 Jul 926.90 -1.01%
16 Jul 907.10 2.20%
15 Jul 884.00 3.04%
14 Jul 867.35 1.35%
11 Jul 859.00 1.79%
10 Jul 855.00 0.58%
09 Jul 855.00 0.01%
08 Jul 860.00 -0.74%
07 Jul 869.30 -1.01%
04 Jul 880.00 -1.22%
03 Jul 888.15 -1.49%
02 Jul 898.95 -1.20%

MedPlus Health Services Limited Graph

MedPlus Health Services Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for MedPlus Health Services Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 934.45, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 935.65 945.01 850.51 - 1,039.51
954.36 763.49 - 1,145.24
963.72 674.60 - 1,252.84
Bearish Scenario 935.65 926.29 833.66 - 1,018.92
916.94 733.55 - 1,100.32
907.58 635.31 - 1,179.85

Overview of MedPlus Health Services Limited

ISIN

INE804L01022

Industry

Medical - Pharmaceuticals

Vol.Avg

179,873

Market Cap

111,894,238,819

Last Dividend

0

Official Website

Visit Website

IPO Date

2021-12-23

DCF Diff

540.73

DCF

394

Financial Ratios Every Investor Needs

Stock Rating Details for MEDPLUS

Metric Value Recommendation
Overall Rating C+ Sell
DCF Score 3 Neutral
ROE Score 3 Neutral
ROA Score 4 Buy
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 6,136.05 Cr 5,616.52 Cr 519.53 Cr 0.0847 0.00 Cr 0.00 Cr 237.26 Cr 150.32 Cr 12.58 535.72 Cr 0.0245
2024-03-31 5,624.86 Cr 4,410.52 Cr 1,214.34 Cr 0.2159 0.00 Cr 625.62 Cr 563.51 Cr 65.47 Cr 5.48 394.09 Cr 0.0116
2023-03-31 4,557.58 Cr 3,557.69 Cr 999.89 Cr 0.2194 0.00 Cr 20.95 Cr 96.09 Cr 49.76 Cr 4.17 311.75 Cr 0.0109
2022-03-31 3,755.38 Cr 2,982.38 Cr 773.00 Cr 0.2058 0.00 Cr 16.88 Cr 162.71 Cr 95.80 Cr 8.29 303.73 Cr 0.0255
2021-03-31 3,050.78 Cr 2,425.03 Cr 625.75 Cr 0.2051 0.21 Cr 14.16 Cr 135.32 Cr 63.86 Cr 6.26 238.21 Cr 0.0209

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 367.22 Cr 3,360.10 Cr 1,620.20 Cr 1,740.5610 Cr 1,119.80 Cr 752.58 Cr 1,345.10 Cr 1,261.75 Cr 0.00 Cr 0.00 Cr 92.08 Cr 576.5940 Cr
2024-03-31 91.21 Cr 3,004.80 Cr 1,427.44 Cr 1,577.9320 Cr 1,009.57 Cr 918.36 Cr 1,340.23 Cr 1,202.69 Cr 15.77 Cr 0.00 Cr 5.10 Cr 525.9350 Cr
2023-03-31 228.38 Cr 2,796.72 Cr 1,306.22 Cr 1,491.1780 Cr 899.92 Cr 671.55 Cr 1,144.09 Cr 1,114.44 Cr 103.18 Cr 0.00 Cr 2.21 Cr 476.5830 Cr
2022-03-31 21.46 Cr 2,594.05 Cr 1,176.80 Cr 1,417.7720 Cr 814.94 Cr 793.48 Cr 914.98 Cr 771.48 Cr 85.33 Cr 0.00 Cr -598.94 Cr 559.0120 Cr
2021-03-31 106.82 Cr 1,565.66 Cr 834.55 Cr 730.5530 Cr 590.21 Cr 483.40 Cr 749.96 Cr 477.58 Cr 71.04 Cr 0.00 Cr -42.28 Cr 414.9400 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 554.4070 Cr -331.6450 Cr -227.9190 Cr 494.9570 Cr 0.0000 Cr 367.2180 Cr -59.4500 Cr 150.3220 Cr 0.0000 Cr 0.0000 Cr -4.8650 Cr
2024-03-31 143.7370 Cr -82.7990 Cr -198.1040 Cr 59.3380 Cr -137.1660 Cr 91.2090 Cr -84.3990 Cr 65.4730 Cr 0.0000 Cr 0.0000 Cr -196.1470 Cr
2023-03-31 90.4100 Cr 429.4410 Cr -170.2490 Cr -78.5950 Cr 349.6020 Cr 228.3750 Cr -169.0050 Cr 47.1630 Cr -88.4110 Cr 0.0000 Cr -229.1030 Cr
2022-03-31 169.8890 Cr -703.1260 Cr 440.4290 Cr 52.1680 Cr -92.8080 Cr -121.2270 Cr -117.7210 Cr 117.9430 Cr -65.6380 Cr 0.0000 Cr -165.0270 Cr
2021-03-31 2.8910 Cr -34.5490 Cr -5.6260 Cr -51.3670 Cr -37.2840 Cr -28.4190 Cr -54.2580 Cr 95.0980 Cr 0.0000 Cr 0.0000 Cr -106.4020 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 1,509.61 Cr 1,367.02 Cr 142.59 Cr 0.0945 72.17 Cr 51.34 Cr 4.30 152.17 Cr 0.0340
2024-12-31 1,561.45 Cr 1,170.58 Cr 390.86 Cr 0.2503 70.06 Cr 45.89 Cr 3.84 145.04 Cr 0.0294
2024-09-30 1,576.17 Cr 1,201.87 Cr 374.30 Cr 0.2375 61.30 Cr 38.74 Cr 3.24 136.04 Cr 0.0246
2024-06-30 1,488.83 Cr 1,381.42 Cr 107.40 Cr 0.0721 167.43 Cr 14.36 Cr 1.20 93.76 Cr 0.0096
2024-03-31 1,490.50 Cr 1,373.71 Cr 116.79 Cr 0.0784 46.65 Cr 33.40 Cr 2.81 116.33 Cr 0.0224

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 367.22 Cr 0.00 Cr 367.22 Cr 13.27 Cr 1,345.10 Cr 1,843.52 Cr 1,261.75 Cr 3,360.10 Cr 1,620.20 Cr
2024-12-31 0.00 Cr 0.00 Cr 267.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1,635.67 Cr
2024-09-30 123.97 Cr 179.09 Cr 303.07 Cr 0.00 Cr 1,340.71 Cr 1,712.39 Cr 1,190.99 Cr 3,155.07 Cr 1,519.40 Cr
2024-06-30 0.00 Cr 0.00 Cr 174.24 Cr 0.00 Cr 0.00 Cr 174.24 Cr 0.00 Cr 0.00 Cr -1,577.36 Cr
2024-03-31 141.68 Cr 83.03 Cr 141.68 Cr 17.50 Cr 1,340.23 Cr 1,567.55 Cr 1,201.38 Cr 3,004.80 Cr 1,427.44 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 45.89 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 38.74 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 14.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 33.40 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 13.73 Cr 114.22 Cr 0.00 Cr 0.00 Cr 78.21 Cr 198.59 Cr 120.38 Cr 0.00 Cr 114.22 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹934.45 ₹111,894,238,819.00 ₹171,045.00

Key Executives

Chief Strategy Officer
Mr. Chetan Dikshit

Gender: male

Year Born:

Chief Operating Officer & Whole Time Director
Dr. Cherukupalli Bhaskar Reddy

Gender: Not Specified

Year Born:

Head of Corporate Secretarial & Governance, Company Secretary and Compliance Officer
Mr. Manoj Kumar Srivastava

Gender: male

Year Born:

Head of Supply Chain
Mr. Kandasamy Vairaperumal

Gender: male

Year Born:

Chief Financial Officer
Mr. Sujit Kumar Mahato

Gender: male

Year Born:

Founder, Chief Executive Officer, MD & Chairman
Dr. Gangadi Madhukar Reddy

Gender: Not Specified

Year Born: 1967

FAQs about MedPlus Health Services Limited

Who is the CEO of the company?

The CEO is Gangadi Madhukar Reddy.

What is the current market price of the stock?

The current price is ₹934.45.

What is the 52-week price range?

The range is ₹616-1045.3.

What is the market capitalization of the company?

The market capitalization is ₹11,189.42 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 74.34.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of MedPlus Health Services Limited (ISIN: INE804L01022) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹11,189.42 crores and an average daily volume of 179,873 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack